The Respiratory Department at St James’s hospital  run a number of both investigator-led and industry centered drug trials in respiratory in conjunction with the CRF.

Current Trials & Studies
Study Name Study TitleStudy TypeSponsorSponsor Type
GALACTIC-1A randomized, double-blind, multicentre, parallel, placebo-controlled study in patients with idiopathic pulmonary fibrosis (IPF) investigating the safety and efficacy of TD139, a dry powder, inhaled galectin-3 inhibitorClinical TrialGalecto Biotech ABIndustry
LusterA 52 week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthmaClinical TrialNovartis Pharma UK LtdCommercial: Industry
MA39297An international trial to characterize the disease behaviour of idiopathic pulmonary fibrosis and interstitial lung disease during the peri-diagnostic periodClinical TrialF Hoffmann- La Roche LtdCommercial: Industry
BAL dccrAirway Gene Expression Profiling and Immune Responses to Lung Disease (BAL)Observational-non invasiveN/ANon-commercial: Academic
Past Trials & Studies
Study NameStudy TitleStudy TypeSponsorSponsor Type
CrystalCrystal - A prospective, multicentre, 12 week, randomized open label study to evaluate the efficacy and safety of glycopyrronium (50 microgrms o.d.) or indacaterol maleate and glycopyrronium bromide fixed dose combination (110/50 micrograms o.d.) regarding symptoms and health status in patients with moderate chronic obstructive pulmonary disease (COPD) switching from treatment with any standard COPD regimenClinical triaNovartisIndustry
PalladiumA multi-centre, randomised, 52 week treatment, double-blind, triple-dummy, parallel-group study to assess the efficacy and safety of QMF149 compared with mometason furoate in patients with asthmaClinical trialNovartis Pharma UK LtdIndustry